This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Finance & Accounting for Bioscience Companies
September 18-19, 2024
Omni Boston Hotel at the SeaportBoston, MA

Adam Weisman
Chief Executive Officer and Co-Founder at Auxilius
Speaker

Profile

Adam Weisman is the Co-founder and CEO of Auxilius, a verticalized software company purpose-built for the unique and complex needs of biopharma clinical trial sponsors. Building off over 16 years of leadership experience within the life science sector, Adam is passionate about solving an unmet need, posed by finance and accounting challenges of clinical trials. Prior to founding Auxilius, Adam served as the Senior Vice President at Decision Resources Group (DRG), overseeing various business units and strategic assets, contributing significantly to its acquisition by Clarivate Analytics. Adam has been immersed within the life science sector and centered-on strategic operations and growth strategies for middle-market bioscience companies, previously as Vice President at IndUS Growth Partners from 2015 to 2019. Earlier, as Director of Venture Development at Redstar Ventures, Adam spearheaded the development of innovative high-tech market solutions.

Agenda Sessions

  • Chairperson’s Welcome Remarks: Finance and Accounting for Bioscience Companies

    8:30am